SCHEMBL15325816

SCHEMBL15325816

COc1ccc(NC(C)c2ccc(OC)c(OC)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
CA1 P00915 2/20 0.51
CA2 P00918 2/20 0.51
ACHE P22303 1/20 0.51
GAA P10253 3/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
CA12 O43570 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
PKM P14618 1/20 0.48
HPGD P15428 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TP53 P04637 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4898808 0.88 CA1 (0.55) ALDH1A1CA1CA2ACHEGAA
SCHEMBL6687727 0.84 ALDH1A1 (0.82) ALDH1A1CA1CA2ACHEGAA
SCHEMBL15003942 0.84 ALDH1A1 (0.82) ALDH1A1CA1CA2ACHEGAA
SCHEMBL16557018 0.81 ALDH1A1 (0.61) ALDH1A1CA1CA2ACHEGAA
SCHEMBL15003943 0.79 ALDH1A1 (0.69) ALDH1A1GAAKDM4ETDP1HPGD
SCHEMBL16574228 0.79 ALDH1A1 (0.69) ALDH1A1GAAKDM4ETDP1HPGD
SCHEMBL30301296 0.79 ALDH1A1 (0.69) ALDH1A1GAAKDM4ETDP1HPGD
SCHEMBL30518163 0.79 ALDH1A1 (0.44) ALDH1A1CA1CA2GAAMAPT
SCHEMBL29078132 0.79 ALDH1A1 (0.44) ALDH1A1CA1CA2GAAMAPT
SCHEMBL29078134 0.79 ALDH1A1 (0.44) ALDH1A1CA1CA2GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2836497-B1 CATALYST COMPOUNDS UNIV LIVERPOOL (GB) 2016-03-23 EP disclosed
US-9212199-B2 Catalyst compounds THE UNIVERSITY OF LIVERPOOL (GB) 2015-12-15 US disclosed
US-20150080592-A1 CATALYST COMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2015-03-19 US disclosed
US-20150073165-A1 CATALYST COMPOUNDS THE UNIVIERSITY OF LIVERPOOL (GB) 2015-03-12 US disclosed
WO-2013153408-A1 CATALYST COMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2013-10-17 WO disclosed
WO-2013153407-A1 CATALYST COMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2013-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150073165-A1 CATALYST COMPOUNDS NQO1, IDH2, IDH3B ALDH1A1 115/4885CA1 1675/4885CA2 3057/4885
US-20150080592-A1 CATALYST COMPOUNDS IDH3B, IDH2, NQO1 ALDH1A1 261/4885CA1 2401/4885CA2 3172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.